Scripps Cardiologist Weighs in on New Cholesterol-Lowering Drug

Dr. Douglas Triffon, MD, expained prescribing PCSK9 inhibitor

Triffon20KUSI-600×375

Just days after federal regulators approved a new kind of drug for lowering cholesterol, Scripps Clinic cardiologist Douglas Triffon, MD, appeared on KUSI TV’s morning news program to discuss the medication.


Dr. Triffon, who was one of the first physicians in San Diego to prescribe the PCSK9 inhibitor, explained how the new medication differs from older drugs such as statins.


He also reviewed results of clinical trials of the drug, known by the brand name Praluent, in a video report by the online health news outlet MedPage Today.


Watch the KUSI TV report: New Cholesterol Drug


Watch the MedPage Today video: What Do We Know in Terms of Data from Trials?

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce